Have a question you want to ask for the next survey? Submit a question.
Understand how physicians are leveraging remote/telemedicine to treat patients, and explore nuances by specialty/geography.
Learn how pharmaceutical and medical technology companies can optimize outreach and content strategies as physicians increasingly shift online.
Physicians share their perspectives on the timeline for returning to “normal” activity levels, and in turn the impact on HCP access for pharma and medtech companies moving forward. Plus, check out our bonus specialty deep-dives across key therapeutic areas.
Doctors share their predictions on when practice activity will recover to “normal” levels, a look at telehealth usage and key challenges faced, and the status of sales rep engagement via remote interactions.
Deep-dive into the frequency and mix of in-person vs. remote pharma sales representative engagements, quality of those engagements, and physicians’ content preferences.
Explore insights on the state of rep engagement today and expected in the next 12 months, physicians’ rep engagement preferences and physicians’ preferred information sources